Retrospective phase clinical and molecular data of patients without treatment with morphological, genetic, immunophenotype classification. Molecular biology (AML-ETO, PMR-RAR alpha, Inv 16, FLT 3, CEBP mutation 50 cases , 100 controls. Address Hospital General de Mexico , Hematology service ( external consult and transfusional area). (Lysis Buffer)